Medical and Pharmaceutical Manitoba Lung Association and BioMark use blood biopsy to tackle radon threat They are organising a feasibility study assessing the efficacy of BioMark's blood test on those exposed to the gas Rowan DunneAugust 9, 2026
AI and Autonomy Tempus AI buys Personalis to strengthen AI-driven cancer monitoring platform The acquisition targets a cancer monitoring market that the companies estimate could reach USD$20 billion Joseph MortonJuly 29, 2026
Medical and Pharmaceutical China’s Westlake University develops palm-sized lung cancer blood test It could surpass current liquid biopsy options after further evaluation Rowan DunneMay 27, 2026